Physiological melatonin levels in healthy older people: A systematic review - PubMed (original) (raw)

Review

Physiological melatonin levels in healthy older people: A systematic review

Rikie M Scholtens et al. J Psychosom Res. 2016 Jul.

Abstract

Objective: Melatonin plays a major role in maintaining circadian rhythm. Previous studies showed that its secretion pattern and levels could be disturbed in persons with dementia, psychiatric disorders, sleep disorders or with cancer. Also ageing is a factor that could alter melatonin levels, although previous research provides contradicting results. As melatonin supplementation is increasingly applied in older persons as sleep medication, it is important to know if melatonin levels decrease in healthy ageing and/or secretion patterns change. The objective of this study is to determine physiological levels and secretion patterns of melatonin in healthy older people.

Methods: We performed a systematic review and searched PubMed and Embase for studies published between January 1st 1980 and October 5th 2015 that measured melatonin in healthy persons aged ≥65years.

Results: Nineteen studies were retrieved. The number of participants ranged from 5 to 60 per study. Melatonin was mostly measured by radioimmunoassay (RIA) and the number of measurements per 24hours varied from 1 to 96. Sixteen studies showed a secretion pattern with a clear peak concentration, mostly at 0200h or 0300h. Maximum concentrations varied greatly from 11.2 to 91.3pgml(-1). Maximum melatonin level in studies with participants mean aged 65-70years was 49.3pgml(-1) and in studies with participants mean aged ≥75years 27.8pgml(-1), p-value <0.001.

Conclusion: Total melatonin production in 24hours seems not to change in healthy ageing, but the maximal nocturnal peak concentration of melatonin might decline. It is important to take this into account when prescribing melatonin supplementation to older people.

Keywords: Aged; Ageing; Circadian rhythm; Elderly; Melatonin; Pineal gland.

PubMed Disclaimer

Cited by

Current Insights into the Risks of Using Melatonin as a Treatment for Sleep Disorders in Older Adults.
Tuft C, Matar E, Menczel Schrire Z, Grunstein RR, Yee BJ, Hoyos CM. Tuft C, et al. Clin Interv Aging. 2023 Jan 12;18:49-59. doi: 10.2147/CIA.S361519. eCollection 2023. Clin Interv Aging. 2023. PMID: 36660543 Free PMC article. Review.
Trough Melatonin Levels Differ between Early and Late Phases of Alzheimer Disease.
Lin CH, Chiu CC, Lane HY. Lin CH, et al. Clin Psychopharmacol Neurosci. 2021 Feb 28;19(1):135-144. doi: 10.9758/cpn.2021.19.1.135. Clin Psychopharmacol Neurosci. 2021. PMID: 33508797 Free PMC article.
Melatonin for Insomnia in Medical Inpatients: A Narrative Review.
Salahub C, Wu PE, Burry LD, Soong C, Sheehan KA, MacMillan TE, Lapointe-Shaw L. Salahub C, et al. J Clin Med. 2022 Dec 29;12(1):256. doi: 10.3390/jcm12010256. J Clin Med. 2022. PMID: 36615056 Free PMC article. Review.
Vivarium Lighting as an Important Extrinsic Factor Influencing Animal-based Research.
Dauchy RT, Blask DE. Dauchy RT, et al. J Am Assoc Lab Anim Sci. 2023 Jan 1;62(1):3-25. doi: 10.30802/AALAS-JAALAS-23-000003. J Am Assoc Lab Anim Sci. 2023. PMID: 36755210 Free PMC article. Review.
Melatonin as an Anti-Inflammatory Agent Modulating Inflammasome Activation.
Favero G, Franceschetti L, Bonomini F, Rodella LF, Rezzani R. Favero G, et al. Int J Endocrinol. 2017;2017:1835195. doi: 10.1155/2017/1835195. Epub 2017 Oct 1. Int J Endocrinol. 2017. PMID: 29104591 Free PMC article. Review.

Physiological melatonin levels in healthy older people: A systematic review - PubMed (original) (raw)